Carbidopa And Levodopa Tablet
Product Images NDC 68071-2240

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 68071-2240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2240 1)

The label for CARBIDOPA AND LEVODOPA 25 mg/100 mg tablets, containing 100 tablets. Manufactured by NuCare Pharmaceuticals, Inc., with distribution by Halo Industries Ltd. in India. The label includes dosage information, storage instructions, a warning to keep out of reach of children, and multiple product identifiers including NDC 68071-2240-1 and GTIN 00368071224016.*

FDA Label Image

Cdld-structure-carbidopa (Cdld Structure Carbidopa)

Chemical structure diagram of the active ingredient in CARBIDOPA AND LEVODOPA tablets by NuCare Pharmaceuticals, Inc., depicting the molecular arrangement including a benzene ring with hydroxyl groups, side chains, and a water molecule (hydrated form).*

FDA Label Image

Cdld-structure-levodopa (Cdld Structure Levodopa)

Chemical structure diagram of the active ingredient in CARBIDOPA AND LEVODOPA, showing a benzene ring with hydroxyl groups and an attached side chain containing an amino group and carboxylic acid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.